` U.S. Department of Health & Human Services (http://www.hhs.gov/)
`
`IRDYE 700DX
`
` National Institutes of Health (http://www.nih.gov/)
`
` (
`
`/structur
`q=78857
`2ad3-
`4870-
`9473-
`d10696fd
`
`Search...
`
`Type
`
`Language
`
` Common Name
`
`English
`
` NCATS (http://www.ncats.nih.gov)
`IRDYE 700DX
`C51A2YUX4N
`Other
`
`
`
`c ___ )
`
` Structure
`
`Details
`
`Stereochemistry
`
`ACHIRAL
`
`Molecular Formula C74H96N12O27S6S
`i3.4Na
`
`Molecular Weight
`
`1954.224
`
`Optical Activity
`
`Defined
`Stereocenters
`
`E/Z Centers
`
`Charge
`
`NONE
`
`0 / 0
`
`0
`
`0
`
`Stereo Comments Coordination
`Compound
`
`SHOW SMILES / InChI
`
`SHOW STEREO...
`
`c ____ )
`
` General
`
`Approval Year
`
`Unknown 139,594 (/substances?facet=Approval Year%2FUnknown)
`
`( __ )
`
` Names
`
`Show 5
`
` entries
`v j
`
`Name
`
`IRDYE 700DX
`
`https://drugs.ncats.io/drug/C51A2YUX4N
`
`1/3
`
`
`
`12/17/24, 1:01 PM
`
`IRDYE 700DX
`
`SILICATE(4-), (2,5-DIOXO-1-PYRROLIDINYL 6-(((3-((29H,31H-
`PHTHALOCYANIN-1-
`YL-.KAPPA.N29,.KAPPA.N30,.KAPPA.N31,.KAPPA.N32)OXY)PROPOXY)CAR
`BONYL)AMINO)HEXANOATO(2-))BIS(N-(3-
`((HYDROXY-.KAPPA.O)DIMETHYLSILYL)PROPYL)-3-SULFO-N,N-BIS(3-
`SULFOPROPYL)-1-PROPANAMIN
`
`IRDYE 700DX NHS ESTER
`
`Showing 1 to 3 of 3 entries
`
`( ___ )
`
` Identifiers
`
`Show 5
`
` entries
`v j
`
` Systematic Name
`
`English
`
` Common Name
`
`English
`
`1
`
`□
`
`Search...
`
`Code System
`
`Code
`
`Type
`
`Description
`
`CAS
`
` 916821-46-0 (https://commonchemistry.cas.org/detail?cas_rn=916821-46-0)
`
`PRIMARY
`
`FDA UNII
`
`C51A2YUX4N
`
`Showing 1 to 2 of 2 entries
`
` Related Substances
`( ____ )
`
`<
`
`PRIMARY
`
`1
`
`□
`
`>
`
`PARENT (SALT/SOLVATE)
`H67AGU8WSA
`(/substance/H67AGU8WSA)
`
`SUBSTANCE RECORD
`C51A2YUX4N
`(/substance/C51A2YUX4N)
`
`IRDYE 700DX FREE ACID
`(/substance/H67AGU8WSA)
`
`IRDYE 700DX
`(/substance/C51A2YUX4N)
`
`https://drugs.ncats.io/drug/C51A2YUX4N
`
`2/3
`
`Previous
`
`Next
`
`Previous
`
`Next
`
`
`
`12/17/24, 1:01 PM
`
`IRDYE 700DX
` NCATS (https://ncats.nih.gov/) |
`NIH (https://www.nih.gov/) |
`PRIVACY ACT (https://ncats.nih.gov/privacy) |
`ACCESSIBILITY (https://ncats.nih.gov/accessibility) |
` DISCLAIMER (/disclaimer)
`HHS VULNERABILITY DISCLOSURE (https://www.hhs.gov/vulnerability-disclosure-
`policy/index.html)
`
`For language access (http://edi.nih.gov/consulting/language-access-program/about) assistance, contact the NCATS
`Public Information Officer (mailto:info@ncats.nih.gov)
`National Center for Advancing Translational Sciences (NCATS),
`6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966
`
`https://drugs.ncats.io/drug/C51A2YUX4N
`
`3/3
`
`